Advertisement
Screener

CHINA BCT PHARMACY GROUP, INC. Stock-Based Compensation

CHINA BCT PHARMACY GROUP, INC. Stock-Based Compensation

CHINA BCT PHARMACY GROUP, INC. reported Stock-Based Compensation of $166.01 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-20.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2013-05-20

  • CHINA BCT PHARMACY GROUP, INC. share-based payment arrangement, noncash expense for the quarter ending 2013-03-31 was $166.01K, a 19.05% increase year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. share-based payment arrangement, noncash expense for the quarter ending 2012-12-31 was $166.01K, a 84.43% decline year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was -$166.01K.
  • CHINA BCT PHARMACY GROUP, INC. share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was -$166.01K.
  • CHINA BCT PHARMACY GROUP, INC. share-based payment arrangement, noncash expense for fiscal 2012 was $637.46K, a 61.14% decline from fiscal 2011.
  • CHINA BCT PHARMACY GROUP, INC. share-based payment arrangement, noncash expense for fiscal 2011 was $1.64M, a 30.82% increase from fiscal 2010.
  • CHINA BCT PHARMACY GROUP, INC. share-based payment arrangement, noncash expense for fiscal 2010 was $1.25M.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2013-03-31$166.01K
10-Q · filed 2013-05-20
$332.01K
derived: sum of 2 quarters · filed 2013-05-20
$166.01K
derived: sum of 3 quarters · filed 2013-05-20
$0.00
derived: sum of 4 quarters · filed 2013-05-20
2012-12-31$166.01K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
$0.00
derived: sum of 2 quarters · filed 2013-04-15
-$166.01K
derived: sum of 3 quarters · filed 2013-04-15
$637.46K
10-K · filed 2013-04-15
2012-09-30-$166.01K
10-Q · filed 2012-11-15
-$332.01K
derived: sum of 2 quarters · filed 2012-11-15
$471.45K
10-Q · filed 2012-11-15
$873.65K
derived: sum of 4 quarters · filed 2013-05-20
2012-06-30-$166.01K
10-Q · filed 2012-08-17
$305.45K
10-Q · filed 2012-08-17
$1.04M
derived: sum of 3 quarters · filed 2013-05-20
$1.04M
derived: sum of 4 quarters · filed 2013-05-20
2012-03-31$139.44K
10-Q · filed 2013-05-20
$1.21M
derived: sum of 2 quarters · filed 2013-05-20
$1.20M
derived: sum of 3 quarters · filed 2013-05-20
$1.20M
derived: sum of 4 quarters · filed 2013-05-20
2011-12-31$1.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
$1.06M
derived: sum of 2 quarters · filed 2013-04-15
$1.06M
derived: sum of 3 quarters · filed 2013-04-15
$1.64M
10-K · filed 2013-04-15
2011-09-30-$2.82K
10-Q · filed 2012-11-15
-$5.61K
derived: sum of 2 quarters · filed 2012-11-15
$574.14K
10-Q · filed 2012-11-15
$1.16M
derived: sum of 4 quarters · filed 2012-11-15
2011-06-30-$2.79K
10-Q · filed 2012-08-17
$571.31K
10-Q · filed 2012-08-17
$1.16M
derived: sum of 3 quarters · filed 2012-08-17
$1.79M
derived: sum of 4 quarters · filed 2012-08-17
2011-03-31$568.52K
10-Q · filed 2012-05-21
$1.16M
derived: sum of 2 quarters · filed 2012-06-12
$1.80M
derived: sum of 3 quarters · filed 2012-06-12
2010-12-31$595.65K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-06-12
$1.23M
derived: sum of 2 quarters · filed 2012-06-12
$1.25M
10-K/A · filed 2012-06-12
2010-09-30$632.49K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$658.21K
10-Q · filed 2011-11-14
2010-06-30$25.72K
10-Q · filed 2011-08-15